Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Seres Therapeutics EPS of $0.47, revenue of $0.74M beats by $0.56M (SeekingAlpha) +++ SERES THERAPEUTICS Aktie -3,42%

ZIMMER BIOMET Aktie

 >ZIMMER BIOMET Aktienkurs 
87.44 EUR    +5.2%    (TradegateBSX)
Ask: 87 EUR / 40 Stück
Bid: 84 EUR / 40 Stück
Tagesumsatz: 55 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>ZIMMER BIOMET Performance
1 Woche: -0,8%
1 Monat: +11,4%
3 Monate: +20,2%
6 Monate: +12,9%
1 Jahr: +6,1%
laufendes Jahr: +10,3%
>ZIMMER BIOMET Aktie
Name:  ZIMMER BIOMET HLDGS DL-01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US98956P1021 / 753718
Symbol/ Ticker:  ZIM (Frankfurt) / ZBH (NYSE)
Kürzel:  FRA:ZIM, ETR:ZIM, ZIM:GR, NYSE:ZBH
Index:  S&P500
Profil:  Zimmer Biomet Holdings, Inc. is a medical device company specializing in musculoskeletal healthcare solutions. The company designs, manufactures, and markets orthopedic reconstructive implants for hips, knees, and shoulders, along with a broad range ..
>Volltext..
Marktkapitalisierung:  16270.7 Mio. EUR
Unternehmenswert:  22365.08 Mio. EUR
Umsatz:  7292.59 Mio. EUR
EBITDA:  2170.47 Mio. EUR
Nettogewinn:  660.12 Mio. EUR
Gewinn je Aktie:  3.35 EUR
Schulden:  6478.97 Mio. EUR
Liquide Mittel:  367.87 Mio. EUR
Operativer Cashflow:  1451.46 Mio. EUR
Bargeldquote:  0.15
Umsatzwachstum:  2.28%
Gewinnwachstum:  -21.95%
Dividende je Aktie:  0.83 EUR
Dividendenrendite:  0.99%
Dividendenschätzung:  1.03%
Div. Historie:  25.06.26 - 0.21072€
31.03.26 - 0.2076€
>weitere anzeigen...
Insiderhandel -
Suchwörter:  ZIMMER BIOMET
Letzte Datenerhebung:  05.08.26
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 193.46 Mio. St.
Frei handelbar: 99.82%
Rückkaufquote: 2.52%
Mitarbeiter: 17000
Umsatz/Mitarb.: 0.42 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 4.35%
Bewertung:
KGV: 24.52
KGV lG: 11.08
KUV: 2.23
KBV: 1.44
PEG-Ratio: -
EV/EBITDA: 10.3
Rentabilität:
Bruttomarge: 61.45%
Gewinnmarge: 9.05%
Operative Marge: 16.57%
Managementeffizenz:
Gesamtkaprendite: 3.39%
Eigenkaprendite: 6.07%
 >Anleihen 
>Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Zahnmedizin/ zahnmedizinische Behandlungen
 
05.08.26 - 13:24
Starke Quartalszahlen beflügeln Zimmer Biomet Aktie (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.26 - 13:01
Zimmer Biomet Holdings Inc. Q2 Income Rises (AFX)
 
WASHINGTON (dpa-AFX) - Zimmer Biomet Holdings Inc. (ZBH) announced a profit for its second quarter that Increases, from last yearThe company's earnings came in at $198.3 million, or $1.03 per shar......
05.08.26 - 12:39
Zimmer Biomet Non-GAAP EPS of $2.07 beats by $0.06, revenue of $2.18B beats by $40M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
05.08.26 - 12:33
Zimmer Biomet Announces Second Quarter 2026 Financial Results (PR Newswire)
 
Second quarter net sales of $2.177 billion increased 4.8% on a reported basis, 4.7% on a constant currency1 basis and 4.0% on an organic constant currency1 basis Second quarter diluted earnings per share were $1.03, an increase of 33.8%; adjusted1 diluted earnings per share were $2.07,......
13.07.26 - 13:33
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results (PR Newswire)
 
WARSAW, Ind., July 13, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its second quarter earnings conference call will be webcast on Wednesday, August 5, 2026 at 8:30 a.m. ET. A news release detailing the......
10.07.26 - 22:00
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now? (Zacks)
 
ZBH is banking on knee growth, robotics and restructuring to drive results, but can macro pressures and competition limit the upside?...
01.07.26 - 16:45
Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal (Zacks)
 
PCRX is set to sell its iovera franchise to ZBH in a deal worth up to $140M as it sharpens focus on biopharmaceutical growth....
30.06.26 - 18:31
Zimmer Biomet Aktie bricht nach Übernahmeankündigung ein (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
30.06.26 - 14:51
Pacira divesting iovera° unit to Zimmer Biomet (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.06.26 - 14:48
Pacira To Sell Iovera Business To Zimmer Biomet; Pacira Shares Up (AFX)
 
WASHINGTON (dpa-AFX) - Pacira BioSciences Inc. (PCRX) on Tuesday announced an agreement to divest its iovera business to Zimmer Biomet Holdings (ZBH) for up to $140 million.The transaction is expe......
30.06.26 - 14:36
Pacira BioSciences Aktie steigt nach Deal mit Zimmer Biomet (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
30.06.26 - 13:33
Pacira BioSciences Announces Agreement to Divest its iovera° Business to Zimmer Biomet (GlobeNewswire EN)
 
-- Pacira to receive up to $140 million with $70 million upfront and up to an additional $70 million in potential future revenue-based milestone payments -- -- Two companies will collaborate on advancing the spasticity program --...
29.06.26 - 17:06
Pixee Medical Names Kristoff Goson CEO, Signaling Major Push for U.S. Market Growth (Business Wire)
 
CAMBRIDGE, Mass.--(BUSINESS WIRE)--#AugmentedReality--Today, Pixee Medical announced the appointment of American healthcare executive Kristoff Goson as new Chief Executive Officer. A former senior executive at Zimmer Biomet, Goson will lead the company's U.S. commercial expansion and global growth strategy as demand increases for more accessible and simplified surgical guidance technologies. Kristoff Goson brings 23 years of leadership at Zimmer Biomet, one of the world's largest orthopedic companies, where he served as Global Vice President & General Manager. He led businesses generating more than $1 billion in annual revenue, scaling multiple orthopedic technology franchises and leading acquisitions including Embody, a sports-medicine innovator, in a deal valued at up to $275M. His decision to join Pixee Medical reflects his conviction that augmented reality will define the next era of accessible, precision orthopedic surgery. Pixee Medical provides an alternative to large footprint, costly surgical r...
18.06.26 - 17:30
Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term (Zacks)
 
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....
15.06.26 - 14:24
Is Zimmer Biomet Stock Underperforming the S&P 500? (Barchart)
 
Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...
02.06.26 - 13:33
Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference (PR Newswire)
 
WARSAW, Ind., June 2, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that members of the Zimmer Biomet management team will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June......
23.05.26 - 08:24
Zimmer Biomet declares $0.24 dividend (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.05.26 - 22:33
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2026 (PR Newswire)
 
WARSAW, Ind., May 22, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the second quarter of 2026. The cash......
18.05.26 - 17:30
Here′s Why Zimmer Biomet (ZBH) is a Strong Value Stock (Zacks)
 
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Um einen Graben zu füllen, muß ein Hügel abgetragen werden. - Sprichwort Armenien
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!